Influence of reporting error on the relation between blood folate concentrations and reported folic acid-containing dietary supplement use among reproductive-aged women in the United States

American Journal of Clinical Nutrition

Volumn 77, Issue 1, 2003, Pages 196-203

  Yang, Quanhe ^a   Erickson, J David ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Blood folate concentration; Folic acid; Misclassification; NHANES III; Third National Health and Nutrition Examination Survey

Indexed keywords

FOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLIC ACID BLOOD LEVEL; HEALTH SURVEY; HUMAN; MEASUREMENT; NORMAL HUMAN; REPRODUCTION; STATISTICAL ANALYSIS; UNITED STATES; VITAMIN SUPPLEMENTATION;

EID: 0037215373     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.1.196     Document Type: Article

References (30)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338:131-7.
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
3. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-90.
4. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999;341:1509-19.
5. Food and Drug Administration. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid, final rule. Fed Regist 1996;61:8781-97.
6. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41:1-7.
7. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B-12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press, 1998.
8. Brown JE, Jacobs DR Jr, Hartman TJ, et al. Predictors of red cell folate level in women attempting pregnancy. JAMA 1997;277:548-52.
9. Wright JD, Bialostosky K, Gunter EW, et al. Blood folate and vitamin B-12: United States, 1988-94. Vital Health Stat 11 1998;243:1-78.
10. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
11. Lewis CJ, Crane NT, Wilson DB, Yetley EA. Estimated folate intakes: Data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr 1999;70:198-207.
12. Folate status in women of childbearing age - United States, 1999. MMWR Morb Mortal Wkly Rep 2000;49:962-5.
13. Cuskelly GJ, McNulty H, Scott JM. Fortification with low amounts of folic acid makes a significant difference in folate status in young women: Implications for the prevention of neural tube defects. Am J Clin Nutr 1999;70:234-9.
14. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001:285:2981-6.
15. Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG, Scott JM. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. Q J Med 1997;90:519-24.
16. Malinow MR, Duell PB, Hess DL, et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998;338:1009-15.
17. Loria CM, Ingram DD, Feldman JJ, Wright JD, Madans JH. Serum folate and cardiovascular disease mortality among US men and women. Arch Intern Med 2000;160:3258-62.
18. Scholl TO, Johnson WG. Folic acid: Influence on the outcome of pregnancy. Am J Clin Nutr 2000;71(suppl):1295S-303S.
19. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608-14.
20. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-94: Reference Manuals and Reports. Hyattsville, MD: National Center for Health Statistics, 1996.
21. Raiten DJ, Fisher KD. Assessment of folate methodology used in the third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). J Nutr 1995;125:1371S-98S.
22. US Department of Agriculture. USDA Nutrient Database for Standard Reference, Release 11. Riverdale, MD: Agriculture Research Service, 1996.
23. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Release 7.0. Research Triangle Park, NC: Research Triangle Institute, 1996.
24. Ford ES, Byers TE, Giles WH. Serum folate and chronic disease risk: Findings from a cohort of United States adults. Int J Epidemiol 1998;27:592-8.
25. Rasmussen LB, Ovesen L, Bulow I, Knudsen N, Laurberg P, Perrild H. Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women. Am J Clin Nutr 2000;72:1156-63.
26. Graham IM, O'Callaghan P. The role of folic acid in the prevention of cardiovascular disease. Curr Opin Lipidol 2000;11:577-87.
27. Lucock M, Daskalakis I. New perspectives on folate status: A differential role for the vitamin in cardiovascular disease, birth defects and other conditions. Br J Biomed Sci 2000;57:254-60.
28. Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: Cause or effect? Am J Clin Nutr 2000;72:315-23.
29. US Department of Health and Human Services. Healthy People 2010. Washington, DC: US Department of Health and Human Services, 2000.
30. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.